## **Core Concept**
C3-nephritic factor (C3NeF) is an autoantibody associated with a subset of membranoproliferative glomerulonephritis (MPGN), specifically with dense deposit disease (DDD) and C3 glomerulopathy. It plays a critical role in the dysregulation of the alternative complement pathway. This condition leads to the persistent activation of the alternative complement pathway.

## **Why the Correct Answer is Right**
The correct answer involves understanding that C3NeF stabilizes the C3 convertase (C3bBb) of the alternative complement pathway, preventing its inactivation. This results in uncontrolled activation of the alternative complement pathway, leading to the consumption of C3 and deposition of C3 and its fragments in the glomeruli, which is a hallmark of C3 glomerulopathy. This mechanism underlies the renal injury observed in patients with this condition.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option might suggest a mechanism not directly related to C3NeF's action on the complement pathway. Without specifics, it's hard to address directly, but if it doesn't involve stabilization of C3 convertase or dysregulation of the alternative complement pathway, it's incorrect.
- **Option B:** If this option does not accurately describe the role of C3NeF in stabilizing C3 convertase or its consequences on complement activation and C3 consumption, it is incorrect.
- **Option D:** Similar to options A and B, if it inaccurately describes the function or effect of C3NeF, it is incorrect.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that C3NeF is a hallmark of a subset of MPGN known as C3 glomerulopathy, which includes dense deposit disease. The presence of C3NeF leads to a poor prognosis, and its detection can guide therapy, which may include eculizumab, a complement inhibitor.

## **Correct Answer:** D. C3NeF helps in the stabilization of C3 convertase.